{"adverse_reactions":["Sincerus Florida, LLC. Adverse reactions z"],"components":["Active, inactive s"],"effective_time":"20190510","id":"888b2203-46a0-d599-e053-2995a90a7de1","instructions_for_use":["Directions for use d"],"openfda":{},"package_label_principal_display_panel":["NDC 72934-1061-2 DAPSONE USP 6% / NIACINAMIDE USP 2% / SPIRONOLACTONE USP 5%. Gel 30gm sf"],"set_id":"888b2203-469f-d599-e053-2995a90a7de1","spl_product_data_elements":["DAPSONE 6% / NIACINAMIDE 2% / SPIRONOLACTONE 5% DAPSONE 6% / NIACINAMIDE 2% / SPIRONOLACTONE 5% NIACINAMIDE NIACINAMIDE DAPSONE DAPSONE SPIRONOLACTONE SPIRONOLACTONE"],"version":"1"}